The debate about treating "low T" in older men will heat up

May 2014

The debate about treating "low T" in older men will heat up...due to controversy over testosterone's cardiovascular risk.

A recent JAMA study has Health Canada and the FDA investigating a possible link between testosterone therapy and heart attacks and strokes.

Critics say the JAMA study is flawed.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Respiratory & Allergy when and how to use spacers with metered-dose inhalers (MDIs)
Antipsychotics The new Abilify Maintena (aripiprazole) will put more focus on avoiding mix-ups with intramuscular "atypical" antipsychotics
Cardiology new approaches to improve medication use in patients who have had a recent heart attack or "MI" (myocardial infarction)
Vaccines more focus on dispensing typhoid vaccines
Testosterone The debate about treating "low T" in older men will heat up
Elderly Patients avoiding high-risk meds in the elderly
PCOS changes in treatment of polycystic ovary syndrome (PCOS)
Supplements Patients are asking if multivitamins are beneficial
Diabetes meds can increase the risk of diabetes
Anticoagulants handling Rxs for oral blood thinners (warfarin, Pradaxa, Xarelto, etc)